Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T22:50:35.561Z.
Calculation as of: 2026-10-06T22:50:35.561Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Baird Medical Investment Holdings Limited
Market Cap
$32.93M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.52M
EBITDA Yield
7.78%
TTM Avg
3.91%
3Y Avg
10.09%
5Y Avg
10.18%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baird Medical Investment Holdings Limited (BDMD) | $32.93M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $32.79M | 6.09% | 3.36% | 3.05% | 3.05% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $32.42M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | N/A | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $33.63M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 7.78% | 3.91% | 10.09% | 10.18% |
| Elutia Inc (ELUT)vs › | $34.35M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $31.11M | N/A | 4.27% | 2.75% | 3.74% |
| CervoMed Inc. (CRVO)vs › | $30.92M | N/A | 392.49% | 233.09% | 233.09% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute